An Analysis On Private Equity Investment Space In China’s Pharmaceutical Chain Industry

China private equity fund is in the early stages of development, gradually attention. Assessment and room for growth in the target company’s analysis is an important part of the decision of private equity funds (PE) investment success or failure of operation. Pharmaceutical retail chain industry is non-cyclical industry, with good investment prospects, as more and more concerned about the investment company investments. From the perspective of private equity firms to examine the development of China’s pharmaceutical chain industry, pharmaceutical chain enterprises and the establishment of evaluation index system, the assessment of the investment industry, investment evaluation system constructed with the industry characteristics.Firstly, the basic theory of the private equity investment described pharmaceutical chain industry development and investment airborne analysis. Secondly, we carried out analysis of the valuation factors for pharmaceutical companies in reference to the existing evaluation indicators and evaluation criteria of the investment bank, combined with the characteristics of the pharmaceutical chain industry to establish the index system of the pharmaceutical chain enterprises of private equity investment. The index system from the business model, competitive environment, operating results and financial position forecasts, management assessment, five aspects of project valuation and financing plan to inspect and assess the investment targets, inspection, and the various factors discussed in a comprehensive. Finally the Shenyang WK Co. Ltd. as an example application of evaluation models, proved to be invested enterprises, a thorough investigation must be in the target company before investing, analysis.